MedTrace Logo

Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia

NCT00900380 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-05-19

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about cancer and the development of drug resistance in patients.

PURPOSE: This laboratory study is examining tissue samples from patients with acute myeloid leukemia to learn more about drug resistance in these patients.

Conditions

Interventions

OTHER

flow cytometry

OTHER

immunological diagnostic method

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Elisabeth Paietta, PhD · Our Lady of Mercy Medical Center

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-28
Primary Completion
2013-12-30
Completion
2013-12-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00900380 on ClinicalTrials.gov